Scinai Immunotherapeutics Ltd.

Scinai Immunotherapeutics Ltd. is a biopharmaceutical company specializing in the development and commercialization of innovative biological products for the treatment of autoimmune and infectious diseases. They are headquartered in Jerusalem, Israel, and boast a state-of-the-art facility for biopharmaceutical product development and manufacturing. Scinai's core focus is on developing nanosized VHH antibodies, known as NanoAbs, which offer significant advantages over traditional antibody therapies in terms of manufacturing, research and development, product characteristics, and patient safety and convenience.

In addition to their internal research and development, Scinai also provides end-to-end CDMO (Contract Development and Manufacturing Organization) services to pharmaceutical and biotech companies. These services include process development and scale-up, analytical methods development, cGMP manufacturing, and pre-clinical and clinical trial design and execution. Scinai leverages its expertise and facilities to support clients in the development and manufacturing of their own innovative biological products.

Scinai Immunotherapeutics Ltd. does not explicitly state its job flexibility policies on its website.

Scinai Immunotherapeutics is a biopharmaceutical company focused on developing, manufacturing, and commercializing innovative inflammation and immunology (I&I) biological products for the treatment of autoimmune and infectious diseases. They specialize in the development of nanosized VHH antibodies (NanoAbs), which offer potential advantages over traditional antibody therapies in terms of manufacturing, R&D, product characteristics, and patient safety and convenience. Scinai also operates a boutique CDMO (Contract Development and Manufacturing Organization) business, providing end-to-end services for early-stage biotech companies developing their own biological drugs.

Scinai Immunotherapeutics promotes a collaborative and results-oriented culture that values innovation and scientific excellence. They are a dedicated and passionate team who work closely together to develop and manufacture innovative immunotherapeutic products for patients with autoimmune and infectious diseases. The company emphasizes diversity and inclusion, welcoming individuals from various backgrounds and identities to join their efforts.

Scinai Immunotherapeutics is committed to fostering a diverse and inclusive workplace, actively seeking qualified candidates from all backgrounds and identities. Their website states that they are an equal opportunity employer, welcoming people of diverse backgrounds and identities. This commitment to diversity extends beyond simply stating their policy; the company emphasizes their dedication to building a team with a broad range of perspectives and experiences, creating an environment where all employees feel valued and respected.